AT10535B - Process for the preparation of a healing serum against diabetes. - Google Patents
Process for the preparation of a healing serum against diabetes.Info
- Publication number
- AT10535B AT10535B AT10535DA AT10535B AT 10535 B AT10535 B AT 10535B AT 10535D A AT10535D A AT 10535DA AT 10535 B AT10535 B AT 10535B
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- healing
- serum
- serum against
- against diabetes
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 5
- 206010012601 diabetes mellitus Diseases 0.000 title description 3
- 230000035876 healing Effects 0.000 title description 2
- 241001465754 Metazoa Species 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 230000001919 adrenal effect Effects 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 claims description 2
- 230000002950 deficient Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 description 7
- 210000004100 adrenal gland Anatomy 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 206010018473 Glycosuria Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 208000005374 Poisoning Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
<Desc/Clms Page number 1>
'Öserreichische
EMI1.1
FIRMA E. MERCK IN DARMSTADT.
Verfahren zur Herstellung eines Heilserums gegen Zuckerkrankheit.
Es wurde gefunden, dass die Nebennieren einen Stoff enthalten, welcher in den Kreislauf gebracht (durch subkutane oder intravenöse Einspritzung) neben schon früher bekannten Erscheinungen regelmässig Glykosurie (Zuckerausscheidung) hervorruft. Diese Glykosurie ist nur eine kurz dauernde (1-2--3 Tage). Es ist nun weiter gelungen, mit diesem in den Nebennieren enthaltenen Gift Tiere so zu behandeln, dass sie nicht nur allmählich immer grössere Dosen vertrugen, sondern dass sich in ihr") n Blute aueh Schutz- stoffe bilden und dass diese Schutzstoffe, auf andere Tiere-auch anderer Gattungen- übertragen, diese ebenfalls gegen die Vergiftung mit nebennierensubstanz zu schützen vermögen.
Es handelt sich hier also um die Erzeugung eines Schutzstoffes oder Gegen- giftes in analoger Weise wie bei anderen bekannten Serumbehandlungen. man kann wie folgt verfahren: Ein Hund erhält eine subkutane Einspritzung von Nebennierensaft, der zwei Hammelsnebennieren entspricht ; es treten bei ihm dann die bekannten Vergiftungserscheinungen auf, er ist 2 bis 3 Tagekrankund scheidet4'l"o Zucker aus. Nachdem er sich wieder erholt hat, erhält er subkutan den Saft von drei Hammers- nehennieren und nachdem er sich dann wieder erholt, in derselben Weise weiter all-
EMI1.2
diesem letzten Eingriff erholt hat, wird ihm Blut entnommen ; dieses Blut enthält nun den Schutzstoff in erheblichen Mengen.
Es werden 20 eern dieses Blutes einem Kaninchen injiziert und diesem dann der Saft von zwei Ilammelsnebennieren eingespritzt. Nun verträgt das Kaninchen diese Behandlung, während sie ohne die Serumeinspritzung starke Glykosurie. schwere Erkrankung und zuletzt den Tod herbeiführt. Das mit dem Serum versehene Tier blieb nicht nur gesund, sondern schied auch keinen Zucker mehr aus. Das
EMI1.3
Die Nebenniere hat nämlich die Aufgabe, gewisse Giftstoffe, die sich im Körper bilden, aufzunehmen und zu entgiften. Bokanntlich werden im Verdauungssystem und in der Lober
EMI1.4
<Desc/Clms Page number 2>
die weitere Umsetzung dos Traubenzuckers verhindern und daher Zuckerkrankheiten u. dgl. herbeiführen. Ihre Wirkung wird nun durch die Schutzstoffe, die nach dem oben beschriebenen Verfahren in dem Serum gewonnen werden, aufgehoben.
<Desc / Clms Page number 1>
'Austrian
EMI1.1
E. MERCK COMPANY IN DARMSTADT.
Process for the preparation of a healing serum against diabetes.
It has been found that the adrenal glands contain a substance which, when introduced into the circulation (by subcutaneous or intravenous injection), regularly causes glycosuria (sugar excretion) in addition to previously known symptoms. This glycosuria is short-lived (1-2-3 days). It has now been possible to treat animals with this poison contained in the adrenal glands in such a way that they not only gradually tolerate ever larger doses, but that protective substances are also formed in their blood and that these protective substances affect other animals -Also of other genera- are also able to protect them against poisoning with adrenal substance.
It is a question of the production of a protective substance or counter-poison in a manner analogous to that of other known serum treatments. one can proceed as follows: a dog is given a subcutaneous injection of adrenal juice equivalent to two mutton adrenal glands; Then the well-known symptoms of poisoning appear in him, he is sick for 2 to 3 days and excretes 4'1 "o sugar. After he has recovered, he receives the sap of three hammer hen kidneys subcutaneously and after he recovers, in continue in the same way
EMI1.2
has recovered from this last procedure, blood is drawn from him; this blood now contains the protective substance in considerable quantities.
Twenty oars of this blood are injected into a rabbit, and the rabbit is then injected with the juice from two ileal adrenal glands. The rabbit can now tolerate this treatment, while without the serum injection they have severe glycosuria. causing serious illness and ultimately death. The animal provided with the serum not only remained healthy, but also no longer excreted any sugar. The
EMI1.3
The adrenal gland is responsible for absorbing and detoxifying certain toxins that form in the body. Known to be in the digestive system and in the lober
EMI1.4
<Desc / Clms Page number 2>
prevent the further implementation of the dextrose and therefore diabetes and the like. bring about. Their effect is now canceled by the protective substances that are obtained in the serum according to the method described above.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT10535T | 1902-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT10535B true AT10535B (en) | 1903-01-26 |
Family
ID=3505557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10535D AT10535B (en) | 1902-04-09 | 1902-04-09 | Process for the preparation of a healing serum against diabetes. |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT10535B (en) |
-
1902
- 1902-04-09 AT AT10535D patent/AT10535B/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU83029A1 (en) | PHARMACEUTICAL APPROACH WITH A CORTICOSTEROID SUBSTANCE | |
| DE69636267T2 (en) | NEW IRON-CHELAT AS AN INHIBITOR FROM IRON-MEDIATED OXYDATION | |
| DE2900203A1 (en) | CANCER-RESISTANT AND CANCER METASTASES PREVENTING MEDICINAL PRODUCT | |
| DE1017744B (en) | Process for obtaining growth-promoting substances for therapeutic purposes | |
| DE2759108A1 (en) | USE OF ALPHA -MERCAPTO-BETA-ARYL-ACRYLIC ACIDS IN INCREASING THE ZINC CONTENT IN SERUM AND TISSUE | |
| DE131648C (en) | ||
| Benwitz | Ultrastruktur mariner Amöben IV. Corallomyxa chattoni n. sp. | |
| EP1528922B1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis | |
| DE3721038A1 (en) | Composition for the treatment of gastric ulcers and chronic gastritis | |
| EP0710480A1 (en) | Pharmaceutical composition comprising L-lactic acid and its use | |
| EP0241498B1 (en) | Analgesic and anti-inflammatory medicine made from plants | |
| DE69813137T2 (en) | PLANT EXTRACT, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN HUMAN AND ANIMAL MEDICINE | |
| DE2110436C3 (en) | Process for the preparation of an antileucopenic and antibody-forming thymus extract from calf thymus | |
| DE358148C (en) | Process for the preparation of serum against diseases of the thyroid gland | |
| Bergner et al. | Untersuchungen zum Stickstoffumsatz im Dickdarm des Wiederkäuers | |
| AT397036B (en) | IGNITION TREATMENT METHOD WITH ANTIOXIDATIVE METAL ORGANIC COMPOUNDS | |
| DE2161897A1 (en) | Solution containing calcium ions for the treatment of calcium deficiency | |
| EP0234019A1 (en) | Use of an aqueous extract of Epilobium angustifolium in a new medical application | |
| WO1985004102A1 (en) | Anti-rheumatic agent | |
| DE646116C (en) | Contrast media for the roentgenological visualization of hollow systems of the body | |
| Klingenberg et al. | Permanent isoproterenol application from an intraperitoneal depot capsule—effects on the heart | |
| DE91372C (en) | ||
| DE427274C (en) | Process for the preparation of a mixture of digitalis glycosides | |
| DE1921752A1 (en) | D-galactosamine hydrochloride to provoke - hepatitis in animals | |
| DE424188C (en) | Process for the production of a healing serum against cancerous tumors u. like |